Automated AI analysis of cardiac magnetic resonance images can be just as accurate as trained clinicians--but 186 times faster. Researchers say the technique can improve evaluations and reduce inconsistencies in interpretation. Cardiovascular MRI is the reference standard to assess the structure and function of a heart's left ventricle, a key imaging biomarker used for clinical decision making and as a clinical trial outcome measure. However, clinical analysis of these MRIs is significantly variable. The analysis is often not standardized, and there are avoidable inconsistencies when using human interpreters, such as noise or bias.

NSF's AI Research Institutes program will support longer-term research than typical grants. The National Science Foundation today announced the creation of a new program that will significantly advance research in AI and accelerate the development of transformational, AI-powered innovation by allowing researchers to focus on larger-scale, longer-term research. The National Artificial Intelligence Research Institutes program anticipates approximately $120 million in grants next year to fund planning grants and up to six research institutes in order to advance AI research and create national nexus points for universities, federal agencies, industries and nonprofits. "Advances in AI are progressing rapidly and demonstrating the potential to transform our lives," said NSF Director France Córdova. "This landmark investment will further AI research and workforce development, allowing us to accelerate the development of transformational technologies and catalyze markets of the future."

Musician Halldór Eldjárn has been drawing a lot of attention recently for his AI-approach to composing, as well as his homemade percussion-playing robots. Here's what has made him the artist he is today. The concept of generating music has always fascinated me. My uncle, Kjartan Ólafsson, has worked in this field for decades, creating an AI-driven music composition software called Calmus. He definitely made me realise it was possible to make a computer write music.

A month ago many computer-driven investors watched astonished as markets were wracked by a financial tempest, with once-hot stocks tumbling and previously shunned sectors enjoying a revival. But for Michael Kharitonov, the chief executive of San Francisco-based Voleon Group, the rapid rotation out of momentum stocks that wrongfooted many investors was "boring". The $6bn-in-assets hedge fund hardly noticed the brief but dramatic reversal. "We saw nothing," he says, with a chuckle. Voleon sees itself as at the vanguard of the next wave of quantitative investing, using machine learning to unearth patterns too faint for others to detect.

Artificial intelligence is the single most transformative tool used across industries today. At this year's MWC Los Angeles, the Global System for Mobile Communications (GSMC) has partnered with the NVIDIA Deep Learning Institute (DLI) to offer hands-on, self-paced training on intelligent video analytics, signal processing, data science, and more, powered by GPUs in the cloud.

Take advantage of our discount rooms at the conference hotel. We are beginning to announce speakers for 2020. Want to join us as a speaker? Check out our proposals page. Jesse Anderson is a data engineer, creative engineer, and managing director of the Big Data Institute. He works with companies ranging from startups to Fortune 100 companies on Big Data. This includes training on cutting edge technologies like Apache Kafka, Apache Hadoop and Apache Spark. He has taught over 30,000 people the skills to become data engineers.

"Mia" is the virtual assistant introduced by Australian digital bank Ubank in February 2019. These aren't the members of a new, all-female rock group, but names that several large banks have been giving to their automated digital assistants. So-called chatbots have become a useful cost-cutting tools for companies with large subscriber bases (think banks, insurance firms and mobile phone operators). As they replace human call-center workers, such bots will help save banks an estimated $7.3 billion in operational costs by 2023, Juniper Research predicts. But the proliferation of bots with female names raises questions about whether they might also perpetuate gender stereotypes, particularly around the notion of women in the role of assistants.

As of this afternoon, select residents of Christiansburg, Virginia can tap drones operated by Google parent company Alphabet's Wing for quick and easy deliveries of packages, over-the-counter medications, snacks, and gifts. The company today revealed that it's become the first to operate a commercial air delivery service directly to homes in the U.S., with the launch of a previously announced pilot involving FedEx Express, Walgreens, and local Virginia retailer Sugar Magnolia. From Walgreens, the first retail pharmacy to partner with Wing in the U.S., drone fleets will ferry over-the-counter medicines and other wellness items to folks' homes. And on the FedEx Express side, recipients living within designated Christiansburg zones who opt in will receive some shipments via drone, in customized boxes. Most orders within the four-mile radius of Wing's distribution facility are fulfilled within about 10 minutes, according to the company.

Machine learning tools are now in use at two-thirds of UK financial institutions, with the technology entering a new phase of maturity and more advanced stages of deployment, according to a survey conducted by the Bank of England.

Disclaimer This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 that can generally be identified by words such as "to transform," "multiyear," "commitment," "to found," "aims," "vision," "potential," "can," "will," "plan," "expect," "anticipate," "committed," or similar terms, or regarding the development or adoption of potentially transformational technologies and business models and the collaboration with Microsoft; or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the healthcare products described in this press release, or regarding potential future revenues from collaboration with Microsoft or such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the collaboration with Microsoft will achieve any or all of its intended goals or objectives, or in any particular time frame.